Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New evidence on the pharmacological management of neuropathic pain.
Alcántara Montero A, Sánchez Carnerero CI. Alcántara Montero A, et al. Among authors: sanchez carnerero ci. Rev Esp Anestesiol Reanim (Engl Ed). 2020 Dec;67(10):574-576. doi: 10.1016/j.redar.2020.05.012. Epub 2020 Oct 10. Rev Esp Anestesiol Reanim (Engl Ed). 2020. PMID: 33046259 English, Spanish. No abstract available.
Emerging therapies in clinical development and new contributions for neuropathic pain.
Alcántara Montero A, Sánchez Carnerero CI, Goicoechea García C. Alcántara Montero A, et al. Among authors: sanchez carnerero ci. Rev Esp Anestesiol Reanim (Engl Ed). 2019 Jun-Jul;66(6):324-334. doi: 10.1016/j.redar.2019.02.003. Epub 2019 Apr 19. Rev Esp Anestesiol Reanim (Engl Ed). 2019. PMID: 31010688 Review. English, Spanish.
Updated Guideline of the Canadian Pain Society for the pharmacological management of chronic neuropathic pain: Does it bring something new?
Alcántara Montero A, Sánchez Carnerero CI. Alcántara Montero A, et al. Among authors: sanchez carnerero ci. Rev Esp Anestesiol Reanim (Engl Ed). 2018 Jun-Jul;65(6):356-358. doi: 10.1016/j.redar.2017.12.012. Epub 2018 Feb 6. Rev Esp Anestesiol Reanim (Engl Ed). 2018. PMID: 29426623 English, Spanish. No abstract available.
Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity.
Nadal X, Del Río C, Casano S, Palomares B, Ferreiro-Vera C, Navarrete C, Sánchez-Carnerero C, Cantarero I, Bellido ML, Meyer S, Morello G, Appendino G, Muñoz E. Nadal X, et al. Among authors: sanchez carnerero c. Br J Pharmacol. 2017 Dec;174(23):4263-4276. doi: 10.1111/bph.14019. Epub 2017 Nov 2. Br J Pharmacol. 2017. PMID: 28853159 Free PMC article.
31 results